Product Images Duloxetine

Duloxetine Delayed-Release 60 mg capsule, quantity 30. The product was manufactured by Ajanta Pharma Ltd. in India and repackaged by RemedyRepack Inc. in Indiana, USA. The product's National Drug Code (NDC) is 70518-2630-01 and the source NDC is 27241-0099-03. Store the medication at 20-26°C (63-77°F) with excursions permitting 15-30°C (59-86°F) according to USP guidelines. See the package insert for directions of use. Keep out of reach of children. Lot number and expiration date are not available.*

DULoxetine is a medication in a delayed-release capsule form with a strength of 60 mg. The quantity of capsules per package is 90. The NDC number is 70518-2630-02, and the source NDC is 27241-0099-90. The manufacturer is Ajanta Pharma Ltd. located in Paithan, India. There is a caution to keep this medication out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. The repackaging of the medication was done by RemedyRepack Inc. located in Indiana, PA.*

This is a description of a medication named DULoxetine that comes in the form of 60 mg capsules, with a quantity of 60 per bottle. It has a National Drug Code (NDC) number of 70518-2630-00 and a Source NDC of 27241-0099-03. It is manufactured by Ajanta Pharma Ltd. in India and repackaged by RemedyRepack Inc. in Indiana. It contains directions for use available on the package insert and it should be stored at temperatures ranging from 20-26°C (63-77°F).*

This data seems to be a graph or chart showing the number of patients who experienced a relapse during treatment with either a placebo or Duloxetine, over a period of time in days. The chart has three axis, the y-axis indicates the number of patients, the x-axis shows time in days and the z-axis has values ranging from 0.4 to 1.0. The treatments are listed at the bottom of the chart.*

The text describes a medical treatment using Duloxetine at doses of 60 or 120 mg once daily for relieving pain. There is a graph showing the percent improvement in pain from the baseline, with values up to 100%, and some illegible characters throughout the text.*

The figure shows the proportion of patients with relapse over time from randomization to relapse in days. The x-axis shows the time in days, while the y-axis shows the proportion of patients. There are two treatment categories, placebo, and DULOXETINE. The proportion of patients with relapse is represented by the line graph for each treatment.*

This is a table showing the percentage of patients improved in pain from baseline for different medications. The medications are listed as Duloxetine 60 mg BID, Duloxetine 60 mg QD, Duloxetine 20 mg QD, and Placebo. However, the actual percentages are not provided. The characters at the bottom are not readable and do not affect the description.*

This is a chart that shows the percentage of patients who showed improvement in pain from baseline. It compares the efficacy of Dulozetine 60mg taken twice daily, Duloxetine 60mg taken once daily, and a placebo. The chart displays a 100% improvement for the Dulozetine 60mg taken twice daily, and percentage values for the other two options.*

This is a record of a medication called Placebo being used along with Duloxetine at 60/120mg per day. The text also shows some numbers and symbols but they do not lead to a clear understanding of the context. The record also mentions "Percent Improvement in Pain from Baseline (BOCF)."*

This is a study or trial that involved a drug called Duloxetine, which was administered once daily at a dose of 60 mg, and compared against a placebo. The figures "100", "210", "220", "230", "240", "250", "60", "70", "80", "90" and "100" possibly represent percentage values showing the improvement in pain from the baseline. There are also some random symbols and characters that may not add any meaning to the description.*